Apoptosis is a critical process in normal mammary gland development and the rapid clearance of apoptotic cells prevents tissue injury associated with the release of intracellular antigens from dying cells. Milk fat globule-EGF-factor 8 (Mfge8) is a milk glycoprotein that is abundantly expressed in the mammary gland epithelium and has been shown to facilitate the clearance of apoptotic lymphocytes by splenic macrophages. We report that mice with disruption of Mfge8 had normal mammary gland development until involution. However, abnormal mammary gland remodeling was observed post-lactation in Mfge8 mutant mice. During early involution, Mfge8 mutant mice had increased numbers of apoptotic cells within the mammary gland associated with a delay in alveolar collapse and fat cell repopulation. As involution progressed, Mfge8 mutants developed inflammation as assessed by CD45 and CD11b staining of mammary gland tissue sections. With additional pregnancies, Mfge8 mutant mice developed progressive dilatation of the mammary gland ductal network. These data demonstrate that Mfge8 regulates the clearance of apoptotic epithelial cells during mammary gland involution and that the absence of Mfge8 leads to inflammation and abnormal mammary gland remodeling.
Introduction
Milk fat is synthesized by differentiated mammary gland epithelial cells and secreted into the ductal lumen enveloped in a portion of the apical plasma membrane termed the milk fat globule membrane (MFGM) (Mather, 1987) . The MFGM is made up of glycoproteins, proteins, cholesterol and phospholipids. In addition to providing nutrition, milk proteins have antimicrobial and antiviral activity, promote the growth of beneficial bacteria and aid in the development of the neonatal digestive tract (Mather, 1987; Lonnerdal, 2003) . Milk proteins may also play a role in mammary gland development. Whey acidic protein and β-casein, two of the most abundant milk proteins, serve as classical markers of epithelial cell differentiation and a developmental role has been suggested for whey acidic protein (Shamay et al., 1992; Hirai et al., 1998; Ikeda et al., 2002) .
Milk fat globule-EGF-factor 8 (Mfge8) is a glycoprotein that makes up part of the MFGM (Stubbs et al., 1990) . Mfge8 found in mouse mammary gland milk consists of a long and short (Mfge8L and Mfge8S) isoform (Oshima et al., 1999) . Both isoforms have two N-terminal Notch-like EGF domains. The second EGF-like domain is highly conserved across species and contains an arginine-glycine-aspartic acid (RGD) sequence which has been shown to bind the αvβ3 and αvβ5 integrins (Hanayama et al., 2002) . The EGF-like domains are followed by two discoidin like Factor 5/Factor 8 domains. The carboxyl-terminal discoidin domains bind phosphatidylserine residues expressed on the surface of apoptotic cells and are essential for Mfge8-mediated uptake of these cells (Hanayama et al., 2002) . Mfge8L contains an additional proline-threonine rich domain inserted between the EGF-like and discoidin domains. Mammary gland Mfge8L transcripts increase with pregnancy and lactation suggesting a specific role for this isoform in the pregnant and lactating mammary gland (Oshima et al., 1999) .
Initial interest in Mfge8 focused on lactadherin, the human orthologue of Mfge8, and its potential role in mammary gland carcinomas (Larocca et al., 1991; Carmon et al., 2002) . More recently, Mfge8 has been shown to facilitate in vitro phagocytosis of apoptotic T-cells by activated peritoneal macrophages and to enhance the in vivo clearance of apoptotic lymphocytes by splenic macrophages (Hanayama et al., 2002; Hanayama et al., 2004) .
The importance of apoptosis throughout mammary gland development (Strange et al., 2001 ) and the ability of Mfge8 to facilitate the clearance of apoptotic leukocytes suggests a potentially important function for Mfge8 in mammary gland development.
Though apoptosis is critical in pre-pregnancy mammary gland development (Humphreys et al., 1996; Humphreys, 1999) , the tissue remodeling that takes place during mammary gland involution requires programmed cell death and removal of approximately 90% of the mammary gland epithelium (Wiseman and Werb, 2002) . Despite this massive cell turnover, mammary gland involution is nearly complete by 10 days, at which time there is scant evidence of apoptotic cells (Fadok, 1999) . For involution to proceed in an orderly fashion apoptotic cells must be cleared quickly and completely and milk remaining in the ductal lumen must be re-absorbed (Wilde et al., 1999) . As epithelial cells undergo apoptosis they are phagocytosed by adjacent epithelial cells or are shed into the ductal lumen where they are engulfed by phagocytic cells (Monks et al., 2005) . Mfge8 on the milk membrane and on the apical surface of viable epithelial cells is in close proximity with apoptotic epithelial cells and is in the ideal location to facilitate rapid and orderly clearance of these cells.
In this study we have generated mice homozygous for a gene trap mutation that disrupts Mfge8 and eliminates the carboxy terminal discoidin domain (Silvestre et al., 2005) . Here we report that despite normal mammary gland development during puberty, Mfge8 mutant mice fail to rapidly clear apoptotic cells and develop progressive inflammation during involution coupled with destruction of mammary gland architecture after successive pregnancies. These studies show that Mfge8 plays a central role in orchestrating post-lactational mammary gland remodeling.
Materials and Methods
Generation of Mfge8 mutant mice, genotyping. Mfge8 mutant mice were generated by blastocyst injection of KST227 embryonic stem cells that harbor an insertion of the pGT1-pfs gene trap-vector in intron 7 of Mfge8 (Silvestre et al., 2005) . The pGT1-pfs vector is designed to trap secretory proteins at the cell surface through its transmembrane domain. Southern blot experiments using a digoxin-labelled (Roche) genomic probe (forward 5' CTGTTCTGATGGTGGTGGTG and reverse 5' TAAGCACCCACGTGTTTGAG) spanning a 580 base pair segment flanking exon 7 detected a 10.5 kilobase BamHI fragment for the wild type allele and an approximately 2.5 kilobase fragment for the mutant allele. Subsequent genotyping was done by PCR. A forward primer K2 (5'TTCTTTCCCTTCAATGGCAC) and the reverse primer R4 (5'CCATATTCCCACGTTTGACC) generated a 402 base pair product for the wild type allele and the forward primer K2 and the reverse primer R73 (5'CGTGTCCTACAACACACACTCCAACC) from the gene trap-vector produced an approximately 260 base pair product for the targeted allele.
Animal husbandry. Mice were housed at the animal care facility at the University of California San Francisco and all studies were approved by the institutional review board.
Mice were maintained on a mixed C57/BL6:129 OLA background. Mutant animals were generated from heterozygous intercrosses and from homozygous-heterozygous mating pairs. For studies of mammary gland development, 8-week-old and 9-month-old nulliparous females and age matched littermates at estrus (as determined by vaginal smear) were used. Age matched littermates at first pregnancy were used for studies of pregnancy, lactation, and involution and litter size was normalized to 4 pups for studies of lactation and involution. Studies of apoptosis during involution were done on mice at first pregnancy with forced involution after 10 days of lactation. Heterozygote mice served as controls in these studies.
β-galactosidase staining. 5 μm frozen sections were air dried and fixed with 10% neutral buffered formalin and incubated in X-gal solution in a humidity chamber at 37 0 C overnight. X-gal solution consisted of 1:30 dilution of X-gal stock (30X X-gal reagent, Pierce) in 5 mM potassium ferrocyanide crystalline, 5 mM potassium ferrocyanide trihydrate, 2 mM magnesium chloride in phosphate buffered saline (PBS). Slides were rinsed with PBS and immersed in 100% ethanol until all precipitate dissolved, counterstained with Eosin Y, and dehydrated and mounted.
Reverse transcription-PCR (RT PCR)
. RNA was isolated from mouse mammary gland using Trizol reagent (Invitrogen) according to the manufacturer's instructions. Single stranded cDNA was transcribed from 3 μg of RNA using the superscript first-strand 6 synthesis system (Invitrogen) and random hexamers. PCR was performed using primers covering exon 7 and 8 (forward primer 5'CGCAAGTTTGAGTTCATCCA, reverse primer 5'GCATTGATCTTGCCCTGATT). Whole mount preparation. The inguinal mammary gland was removed and fixed overnight in Carnoy's solution (3:1 ratio of alcohol/glacial acetic acid), hydrated and stained overnight with carmine alum (0.2% carmine dye and 0.5% aluminum potassium sulfate), dehydrated, defatted with xylene, mounted and photographed. For evaluation of ductal diameter, whole mounts from mice greater than 10 days post involution were photographed and the diameter of the largest primary duct along its course adjacent to the central lymph node (5-15 measurements per duct) was measured using NIH image 1.63.
Development

Morphometry.
For morphometric evaluation of epithelial and fat content of the mammary gland, 5 µm sections were stained with hematoxylin and eosin (H and E) and images were obtained from 10 randomly selected fields (Leica DM 5000 B, 100x) using SPOT software. A grid was superimposed on the digital images and the number of intersections that marked epithelium and adipocytes was counted and expressed as a percentage. The investigator was blinded to the genotype of the sections. For evaluation of the phagocytic index of epithelial cells, 5 µm sections from day 2 of involution were stained with H and E and the number of ingested particles within alveolar epithelial cells was counted from 10 randomly chosen high-powered fields using an oil objective (1000 x). Ingestions were counted as apoptotic particles if a whole apoptotic cell or a round apoptotic body with a clear rim surrounding it (spacious phagosome) was observed within the cytoplasm of an epithelial cell lining the alveolar lumen (Monks et al., 2005) .
The phagocytic index was calculated as the number of ingested particles multiplied by the proportion of epithelial cells with ingested particles. The investigator was blinded to the genotype of the sections.
Immunohistochemistry and immunofluorescence. Mammary glands were removed and fixed in 4% paraformaldehyde overnight and then embedded in paraffin. For H and E staining, 5 μm sections were rehydrated and stained according to standard protocols. For immunohistochemistry, 5 μm sections were boiled for 15 min in 10 mM sodium citrate (pH 6) for antigen retrieval and blocked with H 2 O 2 in methanol and subsequently 2% BSA. Rabbit monoclonal antibody (4F6) directed against Mfge8 was used at 1:20 8 dilution in PBS and 0.5% tween, followed by a 1:200 biotinylated anti-rabbit secondary antibody (Vector), ABC reagent (Vector) and liquid diaminobenzidine substrate (Sigma).
For CD45 staining, a rat anti-mouse monoclonal antibody (BD Biosciences, 1:100 dilution) was used. TUNEL assay was done using a kit from Chemicon (Apoptag) and following manufacturer's instructions. For immunofluorescence, apoptotic cells obtained from mammary gland milk were washed with PBS and cytospin preparations were fixed with 3% PFA and 3% sucrose in PBS, blocked with 5% donkey serum, incubated overnight with anti-activated caspase 3 antibody (1:50 dilution, Cell Signaling) at 4°C, and incubated with a FITC-conjugated secondary antibody (1:100 dilution, Jackson Laboratories) and 4',6-Diamidino-2-phenylindole (Dapi). For immunofluorescence staining of the mammary gland, 5 µ sections of mammary gland tissue frozen in OCT were air dried, fixed in 1% PFA and 3% sucrose, blocked in 5% goat serum, and incubated with anti-CD11b antibody (Serotec,1:100 dilution) for 1 hour followed by 1 hour incubation with a FITC-conjugated goat anti-rat antibody (1:100 dilution, Jackson Laboratories) and Dapi. D) and also in the heart, lung, spleen, brain, kidney, skin, and skeletal muscle (data not shown). RT PCR using primers spanning exons 7 and 8 showed the expected 364 base pair product in heterozygote but not homozygote mutant mice ( Figure 1B ).
Western blots using an antibody (4F6) directed against Mfge8 showed a band at approximately 66 kDa and 53 kDa representing Mfge8L and Mfge8S in heterozygote mice but no band in homozygous mice, suggesting that the epitope recognized by this antibody is in the carboxyl terminal region of Mfge8 deleted by this insertion ( Figure   1C ). Genotyping was performed initially by Southern Blot ( Figure 1D ) and subsequently by PCR ( Figure 1E ).
Given the role of Mfge8 in sperm-egg binding (Ensslin and Shur, 2003) , we counted the number of offspring born to homozygote and heterozygote males paired with heterozygote females. As previously reported for Mfge8 null mice generated by a different targeting strategy (Ensslin and Shur, 2003) , male Mfge8 mutant mice were hypofertile (data not shown). In addition, as reported for another Mfge8-null mouse line (Hanayama et al., 2004) , Mfge8 mutants developed age-dependent splenomegaly and had impaired macrophage-mediated engulfment of apoptotic thymocytes (Silvestre et al., 2005) suggesting that our line of Mfge8 mutants is functionally equivalent to the traditional knockouts.
Mfge8 fusion protein is trapped intracellularly. To evaluate whether the pGT1-pfs gene trap vector produced a fusion protein of the expected size (209 kDa), we performed
Western blots on mammary gland lysates from day 2 of involution using an anti-β- Mfge8 mutant mice have normal development during puberty, pregnancy and lactation. We first examined mammary gland morphology during various developmental stages. At 4 weeks of age, the morphology of the ductal network was variable but we did not observe any consistent differences between homozygote mutants and heterozygote controls in ductal morphology or depth of penetration of the fat pad relative to the central lymph node (Figures 3A and B) . At 8 weeks of age, homozygous mice at estrus 13 occasionally had ductal ectasia and dilatation but the majority of mutants and controls had similar ductal and parenchymal morphology as heterozygous controls as assessed by whole mount and histological sections (data not shown). Histological and whole mount analysis revealed no obvious differences on pregnancy day 18.5 ( Figures 3C and D , and data not shown) and lactation day 10 ( Figures 3E and F , and data not shown).
Morphometric quantification of epithelial content revealed no differences between homozygous and heterozygous females at 8 weeks of age, pregnancy day 18.5, or lactation day 10 ( Figure 3G ). A-D). Ductal dilatation was evident after one pregnancy but became much more dramatic after multiple pregnancies and was apparent in the primary ducts as well as the secondary and tertiary branches (Figures 8 F-H Figure 8H ). Wild type females had similar ductal diameter after multiple pregnancies as compared with heterozygous females and significantly smaller ductal caliber as compared with homozygous females.
C/EBPβ and Epimorphin expression is unchanged in
Mfge8 mutant mice. We next evaluated expression of two genes shown to regulate ductal caliber. C/EBPβ is a nuclear transcription factor that plays a key role in mammary gland morphogenesis (Robinson et al., 1998; Seagroves et al., 1998) and C/EBPβ null mice have dilated mammary gland ducts (Seagroves et al., 1998) . Epimorphin is a stromal morphogenic factor that causes ductal dilatation when expressed in the epithelium of transgenic mice under the whey acidic protein promoter (Hirai et al., 2001) . Epimorphin transgenic mice have altered expression of the C/EBPβ isoforms LAP and LIP. We hypothesized that Mfge8 could act upstream of these factors and that loss of Mfge8 might alter the expression or ratio of C/EBPβ isoforms or up-regulate epimorphin expression. However, C/EBPβ isoform expression and ratio and epimorphin protein levels were unchanged in Mfge8 mutant mice during involution, pregnancy, and lactation (data not shown).
Discussion
In (Lund et al., 1996; Li et al., 1997; Furth, 1999; Wilde et al., 1999) .
During the first 48 hours of involution the basement membrane remains intact and lactation can resume if suckling is reinitiated (Li et al., 1997; Furth, 1999; Wilde et al., 1999) . As involution progresses past 48 hours, proteases are released which cleave the basement membrane and irreversible remodeling of the mammary gland takes place (Lund et al., 1996) . On day 3 and day 4 of involution there is continued programmed cell death of the remaining secretory epithelium (Strange et al., 2001) . The proportion of apoptotic cells in our Mfge8 mutants was not significantly different than controls on day 3 or day 4 of involution despite the fact that the total proportion of apoptotic nuclei was greatest at this time. One possible explanation is that the failure to rapidly clear apoptotic cells in the first 48 hours of involution triggers compensatory pathways that augment clearance on days 3 and 4. Another possibility is that though the greatest proportion of apoptotic nuclei was seen on day 3 of involution, the size and epithelial content of the mammary gland is significantly less at this time then on day 1 or day 2 (data not shown).
Therefore, the absolute number of mammary gland epithelial cells undergoing apoptosis is greatest between 24 and 48 hours after the onset of involution, the time at which Mfge8 mutants had the greatest excess of apoptotic cells.
The cells primarily responsible for clearance of apoptotic cells within the mammary gland are largely unknown. Some researchers favor non-professional phagocytes such as epithelial cells in stage 1 of involution and professional phagocytes such as macrophages in the second stage (Fadok, 1999; Stein et al., 2004) whereas others discount a substantial role for inflammatory cells Monks et al., 2005) . Mfge8 mutants had a 3-fold excess of apoptotic nuclei on day 2 of involution, but clearance had apparently caught up with that in heterozygotes by day 3. It would be tempting to speculate that the increase in inflammatory cells that we observed in involuting Mfge8 mutant mammary glands was responsible for this effect, but this increase was not apparent until day 4 of involution. The paucity of immune cells in the mammary glands at the time of impaired apoptotic cell clearance in combination with the impaired phagocytic capacity of mammary gland epithelial cells suggest that epithelial cells utilize Mfge8 for apoptotic cell clearance. Therefore, our data suggest that epithelial cells utilizing Mfge8 mediate a significant proportion of apoptotic cell clearance during the first 48 hours of involution. As the number of immune cells infiltrating the mammary gland increases with involution, the relative contribution of professional phagocytes to apoptotic cell clearance likely predominates.
The orderly removal of apoptotic cells is necessary to avoid the inflammatory response that accompanies the release of antigens by dying cells (Savill and Fadok, 2000; Hengartner, 2001; Geske et al., 2002) . Our line of Mfge8 mutants developed inflammation during involution that persisted at least until day 10. After involution, Mfge8 mutants developed distortion of the mammary gland architecture and with multiple cycles of pregnancy, involution, and inflammation developed dramatic dilatation of the mammary gland ductal network. Based on the data in the present study we cannot determine whether these progressive abnormalities in ductal architecture were a consequence of delayed clearance of apoptotic cells, increased numbers of inflammatory cells or both.
Mammary gland ductal dilatation is a rare phenotype seen in a few other genetically altered mice (Hirai et al., 1998; Seagroves et al., 1998; Vogel et al., 2001) .
Transgenic mice that express epimorphin in the mammary gland epithelium under the whey acidic protein promoter have ductal dilatation and an abnormal ratio of the C/EBPβ isoforms (Hirai et al., 2001) . C/EBPβ null mice also have pubertal ductal dilatation (Seagroves et al., 1998) . However we found no differences in LAP/LIP and epimorphin expression during pregnancy, lactation and involution in Mfge8 mutants or controls.
Thus, the ductal dilatation seen in Mfge8 mutant mice appeared not to be mediated by the C/EBPβ isoforms LAP or LIP or epimorphin.
Our line of Mfge8 mutants were generated using a gene trapping vector that disrupts Mfge8 and produces a fusion protein that is retained in the endoplasmic reticulum and rapidly degraded (Mitchell et al., 2001; Silvestre et al., 2005) . Though we cannot exclude the possibility that the fusion protein may have had deleterious effects on the mammary gland, our comparison of multiparous wild type and heterozygous females revealed minimal differences in ductal morphology. This suggests that the fusion protein was not responsible for the phenotype we observed in the mammary glands of homozygous females. In addition, our mutants had similar phenotypes to traditional Mfge8 knockouts described in the literature (Ensslin and Shur, 2003; Hanayama et al., 2004; Silvestre et al., 2005) The degree of ductal dilatation was quantified by measuring the diameter of the largest primary duct adjacent to the central lymph node using NIH image software (NIH image 1.63). Ductal dilatation was present after 1 pregnancy and there was a three-fold increase in ductal size after multiple (greater than 5) pregnancies (n = 4 for comparisons of 9-month-old and virgin mice, n = 3 for comparisons of ductal size after 1 and 2 pregnancies, and n = 5 for comparisons of multiple pregnancies, * p < 0.01 when comparing multiparous homozygous females with multiparous heterozygous or wild type females, data expressed as mean + s.e.m.) (Bar = 0.2 mm).
